期刊文献+

肺重复癌外科治疗新观念 被引量:3

原文传递
导出
摘要 肺癌患者手术治疗后发生肺重复癌的危险眭相对较高,肺重复癌发病率有升高的趋势。近年来人们对肺重复癌的认识和外科治疗取得了一些新进展。一是对肺重复癌概念和诊断标准的新认识;二是肺重复癌、肺癌复发、转移癌鉴别诊断中出现的新技术;三是肺重复癌外科治疗新方法及其对预后的影响。现就以上几方面分别进行论述。
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第23期1653-1655,共3页 National Medical Journal of China
  • 相关文献

参考文献20

  • 1Robinson CL, Jackson CA. Multiple primary cancer of the lung. J Thorac Surg, 1958, 36:166-173.
  • 2Detterbeck FC, Jones DR, Kernstine KH, et al. Special treatment issues. Chest, 2003, 123:244-258.
  • 3Keogan MT, Tung KT, Kaplan DK, et al. The significance of pulmonary nodules detected on CT staging for lung cancer. Clin Radiol, 1993, 48:94-96.
  • 4李军杰,车国卫,唐小军,周清华.同期性肝肺重复癌一例报告[J].中国肺癌杂志,2006,9(1):54-54. 被引量:1
  • 5Huang J, Behrens C, Wistuba I, et al. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol, 2001, 5: 321- 329.
  • 6Fleisher AG, McElvaney G, Robinson CL. Multiple primary bronchogenic carcinomas: treatment and follow-up. Ann Thorac Surg, 1991,51:48-51.
  • 7Angeletti CA, Mussi A, Janni A, et al. Second primary lung cancer and relapse: treatment and follow-up. Eur J Cardiothoracic Surg, 1995, 9:607-611.
  • 8Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage 1 nonsmall cell lung cancer. Ann Thorac Surg, 2003, 76:1001-1007.
  • 9Wet P, Utta E, Haas V. What can thoracic surgery accomplish in recurrent/second carcinoma of non-small-cell bronchial carcinoma? Kongressbd Dtsch Ges Chir Kongr, 2002, 119:785-791.
  • 10Battafarano RJ, Force SD, Meyers BE, et al. Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg, 2004, 127:836-842.

二级参考文献3

  • 1Martini N,Melamed MR.Multiple primary lung cancers.J Thorac Cardiovasc Surg,1975,70(4):606-612.
  • 2Duchateau CS,Stokkel MP.Second primary tumors involving non-small cell lung cancer:prevalence and its influence on survival.Chest,2005,127(4):1152-1158.
  • 3Braakhuis BJ,Tabor MP,Kummer JA,et al.A genetic explanation of Slaughters concept of field cancerization:evidence and clinical implications.Cancer Res,2003,63(8):1727-1730.

同被引文献20

  • 1Travis WD, Elizabeth Brambilla, Konrad H, et al. World Health Organization classification of tumors. Pathology and genetics, tumors of the lung, pleura, thymus and heart [ M]. Lyon: IARC Press, 2004:44-66.
  • 2Detterbeck FC, Jones DR, Kernstine KH, et al. Lung cancer. Special treatment issues [ J]. Chest, 2003,123 (1 Suppl):244S-258S.
  • 3Iyoda A, Hiroshima K, Nakatani Y, et al. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma [ J]. Ann Thorac Surg, 2007,84 (2) :702-707.
  • 4郭海周,张春芳,王卫杰.双原发性肺癌的诊治[J].医学临床研究,2007,24(7):1228-1229. 被引量:9
  • 5M Nakata,S Sawada,M Yamashita,H Saeki,A Kurita,S Takashima,K Tanemoto.Surgical treatments for multiple primary adenocarcinoma of the lung. The Annals of Thoracic Surgery . 2004
  • 6Karahalil, B,Bohr, VA,Wilson, DM.Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk[J]. EN . 2012 (10)
  • 7Tabish Hussain,Ashwin Kotnis,Rajiv Sarin,Rita Mulherkar.Genetic susceptibility to multiple primary neoplasms in the upper aero-digestive tract: Genotype Score and phenotype correlation[J]. Cancer Letters . 2013 (1)
  • 8Augusto Nogueira,Joana Assis,Raquel Catarino,Rui Medeiros.DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients[J]. Pharmacogenomics . 2013 (6)
  • 9Szeto, YT,Lee, AKH,Benzie, IFF,Obied, HK.Optimized noninvasive procedures to measure DNA damage in comet assay[J]. EN . 2012 (11)
  • 10Laura Marabini,Rossella Calò,Pier Braga.Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells[J]. Arzneimittelforschung . 2011 (12)

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部